HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double-blind placebo-controlled trial.

Abstract
Experimental studies have suggested the beneficial effects of curcuminoids as natural polyphenols against traumatic brain injury (TBI). The aim of this study was to investigate the effects of supplementation with curcuminoids on inflammatory and oxidative stress biomarkers, clinical outcomes and nutritional status in critically ill patients with TBI. A total of 62 ICU-admitted adult patients with TBI were randomly allocated to receive either a daily dose of 500 mg curcuminoids or matched placebo via enteral nutrition for 7 consecutive days based on stratified block randomization by age and sex. Inflammatory and oxidative stress as well as clinical outcomes and nutritional status of the patients were measured at baseline and at the end of the study. There were no overall group effects regarding to all dependent variables. Compared with baseline, serum levels of IL-6, TNF-α, MCP-1 and CRP were significantly reduced in patients receiving curcuminoids (p < .05) without any significant changes in placebo group; however, changes in the activities of GPx and SOD in serum were not significant between two groups. Moreover, APACHEII and NUTRIC score were significantly improved following curcuminoids consumption in comparison with placebo (p < .05). The findings of this study suggest that short-term supplementation with curcuminoids may have beneficial effects on inflammation, clinical outcomes and nutritional status of critically ill patients with TBI.
AuthorsHoda Zahedi, Mohammad Javad Hosseinzadeh-Attar, Mahdi Shadnoush, Amirhossein Sahebkar, Bahareh Barkhidarian, Omid Sadeghi, Atabak Najafi, Saeed Hosseini, Mostafa Qorbani, Arezoo Ahmadi, Seyed Hossein Ardehali, Abdolreza Norouzy
JournalPhytotherapy research : PTR (Phytother Res) Vol. 35 Issue 8 Pg. 4605-4615 (Aug 2021) ISSN: 1099-1573 [Electronic] England
PMID34080237 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2021 John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • Cytokines
  • Diarylheptanoids
  • Curcumin
Topics
  • Adult
  • Biomarkers (metabolism)
  • Critical Illness
  • Curcumin (chemistry)
  • Cytokines (blood)
  • Diarylheptanoids (pharmacology)
  • Dietary Supplements
  • Double-Blind Method
  • Humans
  • Inflammation (drug therapy)
  • Nutritional Status
  • Oxidative Stress (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: